Health Care & Life Sciences » Pharmaceuticals | Entia Biosciences Inc.

Entia Biosciences Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Net Income before Extraordinaries
1,264.10
3,104.80
2,296.60
2,260.10
1,395.80
Depreciation, Depletion & Amortization
21.50
36.00
38.00
32.00
17.70
Other Funds
-
-
40.00
-
-
Funds from Operations
624.80
1,379.60
1,259.00
1,365.60
1,197.40
Changes in Working Capital
310.20
612.80
578.70
829.00
482.30
Net Operating Cash Flow
314.60
766.70
680.30
536.60
715.10
Capital Expenditures
63.30
64.60
45.50
21.30
7.10
Net Investing Cash Flow
63.30
64.60
45.50
21.30
7.10
Issuance/Reduction of Debt, Net
47.40
154.30
523.30
77.70
774.10
Net Financing Cash Flow
374.40
855.10
788.30
482.50
774.10
Net Change in Cash
3.60
23.80
62.60
75.30
51.90
Free Cash Flow
331.80
819.30
684.90
544.60
715.10
Change in Capital Stock
327.00
700.90
225.00
560.20
-

About Entia Biosciences

View Profile
Address
13565 SW Tualatin-Sherwood Road
Sherwood Oregon 97140
United States
Employees -
Website http://www.entiabio.com
Updated 07/08/2019
Entia Biosciences, Inc. operates as a biotechnology company engaged in the discovery, formulation, production and marketing of functional ingredients that can be used in branded medical foods, nutraceuticals, cosmetics and other products. The company through its subsidiary Total Nutraceutical Solutions, Inc. market nutraceutical products under the GROH and SANO brands direct to consumers online and through hair salons and other resellers in North America. Total Nutraceutical Solutions currently offers three natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds.